Overview
Lown-Ganong-Levine (LGL) syndrome is a now-obsolete clinical diagnosis that was historically described as a form of cardiac pre-excitation syndrome. It was characterized by a short PR interval (less than 120 milliseconds) on electrocardiogram (ECG), normal QRS complex duration, and episodes of paroxysmal supraventricular tachycardia (rapid heart rhythms originating above the ventricles). The condition was thought to involve an accessory pathway bypassing the atrioventricular (AV) node, sometimes referred to as James fibers, which would allow electrical impulses to reach the ventricles faster than normal, predisposing patients to re-entrant tachyarrhythmias. The syndrome primarily affects the cardiovascular system. Patients may experience palpitations, dizziness, lightheadedness, or syncope (fainting) during episodes of tachycardia. In some cases, the arrhythmias could be hemodynamically significant. The designation of LGL syndrome as obsolete reflects the evolution of understanding in cardiac electrophysiology. Modern electrophysiological studies have shown that a short PR interval alone is a nonspecific finding and does not reliably indicate a distinct accessory pathway syndrome. Many patients previously diagnosed with LGL syndrome are now reclassified under other arrhythmia diagnoses or are considered to have enhanced AV nodal conduction without a true bypass tract. Treatment, when needed for symptomatic tachyarrhythmias, may include antiarrhythmic medications, vagal maneuvers, or catheter ablation of identified accessory pathways or arrhythmia circuits, depending on the underlying electrophysiological mechanism identified.
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Lown-Ganong-Levine syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Lown-Ganong-Levine syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Lown-Ganong-Levine syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Lown-Ganong-Levine syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Lown-Ganong-Levine syndrome.
Start the conversation →Latest news about OBSOLETE: Lown-Ganong-Levine syndrome
No recent news articles for OBSOLETE: Lown-Ganong-Levine syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Lown-Ganong-Levine syndrome
What is OBSOLETE: Lown-Ganong-Levine syndrome?
Lown-Ganong-Levine (LGL) syndrome is a now-obsolete clinical diagnosis that was historically described as a form of cardiac pre-excitation syndrome. It was characterized by a short PR interval (less than 120 milliseconds) on electrocardiogram (ECG), normal QRS complex duration, and episodes of paroxysmal supraventricular tachycardia (rapid heart rhythms originating above the ventricles). The condition was thought to involve an accessory pathway bypassing the atrioventricular (AV) node, sometimes referred to as James fibers, which would allow electrical impulses to reach the ventricles faster t